Dáil Éireann Debate, Wednesday - 15 January 2014
894. Deputy Michael McGrath asked the Minister for Health the position regarding the drug, anafranil, which is prescribed to patients with severe depression; and if he will confirm its continued availability here for patients who are taking it long term. [1605/14]
Amharc ar fhreagraMy Department is aware of a disruption in supply of Anafranil 10mg, 25mg and 50mg capsules (immediate release) on the Irish and UK market. The disruption relates to manufacturing issues which the marketing authorisation holder Novartis is working to resolve. Supply of Anafranil SR 75mg prolonged-release tablets remain unaffected.
The supply issue should not affect patients who are on maintenance treatment with Anafranil SR 75mg tablets which is used where a patient has been stable on Anafranil for some time.
